Compare AU

Compare IISV vs. IXJ

Compare shares and ETFs on the ASX that you can trade on Pearler.

Intell Investor Select Value Shr Fund - Active ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Intell Investor Select Value Shr Fund - Active ETF (IISV) and the iShares Global Healthcare ETF (IXJ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

IISV

IXJ

Popularity

Low

Low

Pearlers invested

11

241

Median incremental investment

$665.13

$1,000.00

Median investment frequency

Monthly

Monthly

Median total investment

$4,559.49

$1,671.24

Average age group

26 - 35

26 - 35


Key Summary

IISV

IXJ

Strategy

IISV.AX was created on 2023-03-31 by Intelligent Investor . The fund's investment portfolio concentrates primarily on total market equity. The portfolio aims to outperform the S&P/ASX 200 Accumulation Index p.a. over five year rolling periods with minimal turnover to allow returns to compound in a favourable tax environment

IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks

Top 3 holdings

RPMGlobal Holdings Ltd (7.77 %)

Fairfax Financial Holdings Ltd Shs Subord.Vtg (6.95 %)

KKR & Co Inc Ordinary Shares (5.57 %)

Eli Lilly and Company (8.25 %)

UnitedHealth Group Incorporated (5.81 %)

Johnson & Johnson (4.72 %)

Top 3 industries

Financials (50.65 %)

Consumer Discretionary (15.93 %)

Information Technology (14.85 %)

Other (99.98 %)

Communication Services (0.02 %)

Top 3 countries

United States (42.65 %)

Australia (20.03 %)

United Kingdom of Great Britain and Northern Ireland (15.60 %)

United States (99.97 %)

Management fee

0.97 %

0.46 %


Key Summary

IISV

IXJ

Issuer

Intelligent Investor

iShares

Tracking index

S&P/ASX 200 Accumulation Index - AUD - Benchmark TR Net

S&P Global 1200 Healthcare Sector Index - AUD

Asset class

ETF

ETF

Management fee

0.97 %

0.46 %

Price

$3.54

$138.91

Size

N/A

$1.373 billion

10Y return

N/A

123.15 %

Annual distribution yield (5Y)

0.07 %

1.26 %

Market

ASX

ASX

First listed date

30/03/2023

11/03/2009

Purchase fee

$6.50

$6.50


Community Stats

IISV

IXJ

Popularity

Low

Low

Pearlers invested

11

241

Median incremental investment

$665.13

$1,000.00

Median investment frequency

Monthly

Monthly

Median total investment

$4,559.49

$1,671.24

Average age group

26 - 35

26 - 35


Pros and Cons

IISV

IXJ

Pros

  • Higher exposure to AU market

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

  • Lower exposure to AU market

IISV

IXJ

Higher exposure to AU market

Lower exposure to AU market

Lower exposure to US market

Higher exposure to US market

Higher management fee

Lower management fee

Lower price growth

Higher price growth

Lower distribution yield

Higher distribution yield

Home